Literature DB >> 1063349

A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population.

S K Young, N H Rowe, R A Buchanan.   

Abstract

One thousand thirty-one dental and dental hygiene students, faculty and staff at The University of Michigan School of Dentistry were interviewed in order to identify those with a past history of perioral mucocutaneous herpetic infection. Subsequently, the population was followed for 9 (+/- 3) months in order to determine various parameters of disease expression. Analysis of the results indicate the following: 1. In this professional population, 20.5 per cent described prior experience with perioral herpes. No sex difference was noted. 2. Prevalence increased with age. In the faculty-staff group (mean age 32.9 years +/ 11.8) prevalence was 30.7 per cent, whereas in the student -roup (mean age, io.6 years+/- 3.8) prevalence was 17.7 per cent. Occupational and/or socioeconomic factors did not appear to account for the age-related difference in prevalence. 3. Only 40 per cent of those who related prior disease experience developed lesions within the observation period of 9 (+/-3) months. 4. The recurrence rate, based upon an observation period of 9 (+/-3) months, in those persons who related prior disease experience was found to be 1.3 episodes per year (0.1 per month). 5. Duration of lesions ranged between 3 and 17 days, with a mean of 9 days. 6. The lower lip was the most common site of a lesion. 7. Triggering factors associated with development of a lesion in order of decreasing frequency were found to be; emotional stress, exposure to sun, and illness.

Entities:  

Mesh:

Year:  1976        PMID: 1063349     DOI: 10.1016/0030-4220(76)90277-2

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  10 in total

1.  Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics.

Authors:  Julie A Ribes; Angela Smith; Marie Hayes; Doris J Baker; Jeffrey L Winters
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies.

Authors:  Spotswood L Spruance; Terry M Jones; Mark M Blatter; Mauricio Vargas-Cortes; Judy Barber; Joanne Hill; Donna Goldstein; Margaret Schultz
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

3.  Prevention of recurrent herpes labialis outbreaks through low-intensity laser therapy: a clinical protocol with 3-year follow-up.

Authors:  Carlos de Paula Eduardo; Letícia Mello Bezinelli; Fernanda de Paula Eduardo; Roberta Marques da Graça Lopes; Karen Müller Ramalho; Marina Stella Bello-Silva; Marcella Esteves-Oliveira
Journal:  Lasers Med Sci       Date:  2011-11-16       Impact factor: 3.161

4.  Epidemiology and natural history of ocular herpes simplex virus infection in Rochester, Minnesota, 1950-1982.

Authors:  T J Liesegang
Journal:  Trans Am Ophthalmol Soc       Date:  1988

5.  Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.

Authors:  R J Klein; E DeStefano; E Brady; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

6.  Herpes simplex virus reactivation and dental procedures.

Authors:  L El Hayderi; P Delvenne; E Rompen; J M Senterre; A F Nikkels
Journal:  Clin Oral Investig       Date:  2013-04-21       Impact factor: 3.573

7.  Successful treatment of herpes labialis with topical acyclovir.

Authors:  A P Fiddian; J M Yeo; R Stubbings; D Dean
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

8.  A series of in vitro and human studies of a novel lip cream formulation for protecting against environmental triggers of recurrent herpes labialis.

Authors:  Christoph F Gfeller; Rita Wanser; Harish Mahalingam; David J Moore; Xuying Wang; Connie B Lin; Gilbert Shanga; Gary Grove; Anthony V Rawlings
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-03-22

Review 9.  Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis.

Authors:  Farah Wasim Aribi Al-Zoobaee; Loo Yee Shen; Sajesh K Veettil; Divya Gopinath; Mari Kannan Maharajan; Rohit Kunnath Menon
Journal:  Int J Environ Res Public Health       Date:  2020-11-30       Impact factor: 3.390

Review 10.  Diagnosis of viral disease and the advent of antiviral drugs.

Authors:  E C Herrmann; J A Herrmann
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.